Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HEXO, Prudential Financial, Fiat Chrysler, and Merit Medical Systems and Encourages Investors to Contact the Firm
View original at globenewswire.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HEXO, Prudential Financial, Fiat Chrysler, and Merit Medical Systems and Encourages Investors to Contact the Firm NEW YORK, Jan…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Second quarter 2019 revenue reductions attributed to slower than anticipated conversion and uptake of acquired products
80% confidenceChange in mortality assumptions would require a negative earnings impact of $25 million per quarter for the foreseeable future, wiping out approximately one third of the earnings attributable to the Individual Life business segment
80% confidence2020 guidance off the table until they had reasonable confidence in their forecasting ability
80% confidenceThe alleged bribery scheme was authorized at the highest levels of Fiat Chrysler, including the Company's late Chief Executive Officer Sergio Marchionne
80% confidenceFiat Chrysler corrupted collective bargaining agreements between GM and UAW in 2009, 2011, and 2015 by paying millions in dollars in bribes
80% confidenceMany operational failures were due to their own overestimation and forecasting
80% confidenceHEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada
80% confidenceHEXO defendants failed to disclose that reported inventory was misstated as company was failing to write down or write off obsolete product that no longer had value
80% confidenceThe integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule
80% confidencePrudential's reserve assumptions failed to account for adversely developing mortality experience in its Individual Life business segment
80% confidenceHEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors
80% confidencePrudential was not over-reserved, but instead its reported reserves, particularly for the Individual Life business segment, were insufficient to satisfy its future policy benefits liabilities
80% confidenceChanges in mortality assumptions had negatively impacted the Company's results and would trim near-term momentum
80% confidenceSales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019
80% confidence